AMPCX
Price
$30.22
Change
-$1.09 (-3.48%)
Updated
Apr 10 closing price
Net Assets
81.12B
GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
Ad is loading...

AMPCX vs GFACX

Header iconAMPCX vs GFACX Comparison
Open Charts AMPCX vs GFACXBanner chart's image
American Funds AMCAP C
Price$30.22
Change-$1.09 (-3.48%)
VolumeN/A
Net Assets81.12B
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
AMPCX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMPCX vs. GFACX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPCX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. AMPCX (81.1B). AMPCX (0.00) and GFACX (0.00) have matching dividends . AMPCX was incepted earlier than GFACX: AMPCX (24 years) vs GFACX (24 years). AMPCX (1.42) and GFACX (1.36) have similar cost to investors . AMPCX is a more actively managed with annual turnover of: 27.00 vs. GFACX (25.00). AMPCX (250) and GFACX (250) have matching initial minimum investment requirements. GFACX annual gain was more profitable for investors over the last year : -3.95 vs. AMPCX (-7.26). GFACX return over 5 years is better than : 40.74 vs. AMPCX (22.93).
AMPCXGFACXAMPCX / GFACX
Total Expense Ratio1.421.36104%
Annual Report Gross Expense Ratio1.421.36104%
Fund Existence24 years24 years-
Gain YTD-7.695-7.732100%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets81.1B272B30%
Annual Yield % from dividends0.000.00-
Returns for 1 year-7.26-3.95184%
Returns for 3 years-2.224.35-51%
Returns for 5 years22.9340.7456%
Returns for 10 years17.3138.8245%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings